ORAGENICS, INC. Proceeds from Unsecured Lines of Credit
ORAGENICS, INC. (OGEN) reported Proceeds from Unsecured Lines of Credit of $4.00 million for the 9-month period ending 2011-09-30, per its 10-Q filed 2011-11-14.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromUnsecuredLinesOfCredit · last filed 2011-11-14
- ORAGENICS, INC. proceeds from unsecured lines of credit for the quarter ending 2011-09-30 was $1.50M.
- ORAGENICS, INC. proceeds from unsecured lines of credit for the quarter ending 2010-09-30 was $0.00.
| Period end | Proceeds from Unsecured Lines of Credit 3 month | Proceeds from Unsecured Lines of Credit 6 month | Proceeds from Unsecured Lines of Credit 9 month |
|---|---|---|---|
| 2011-09-30 | $1.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $4.00M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.50M 10-Q · filed 2011-08-05 | ||
| 2010-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.00M 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $1.00M 10-Q · filed 2011-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |